EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia

Marco Becilli, Franco Locatelli

Molecular Therapy Oncology · 2026-06 · 34 (2) · 201208

DOI: 10.1016/j.omton.2026.201208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Oncology, 2026-06. Verfasst von Marco Becilli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Bambin…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last decade, CD19-targeting chimeric antigen receptor (CAR) T cell therapy has emerged as a major breakthrough in the treatment of B-cell malignancies, leading to significantly improved outcomes in both children and adults with relapsed/refractory (R/R) acute lymphoblastic leukemia.1 However, replicating these results in the setting of acute myeloid leukemia (AML), refractory or relapsing after conventional or even innovative approaches, has proven challenging. For patients with R/R AML, outcomes remain dismal, and allogeneic hematopoietic stem cell transplantation (HSCT) represents the only potentially curative option, provided that a new complete remission is achieved, ideally with measurable residual disease (MRD) negativity.

Autor:innen und Institutionen

  • Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Bambino Gesù Children's Hospital, Rome, Italy.
  • Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy.

Zitieren

APA

Becilli, M., & Locatelli, F. (2026). Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia. Molecular Therapy Oncology, 34(2), 201208. https://doi.org/10.1016/j.omton.2026.201208

Vancouver

Becilli M, Locatelli F. Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia. Molecular Therapy Oncology. 2026;34(2):201208. doi:10.1016/j.omton.2026.201208

BibTeX
@article{Becilli2026,
  author = {Becilli, Marco and Locatelli, Franco},
  title = {Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia},
  journal = {Molecular Therapy Oncology},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {201208},
  doi = {10.1016/j.omton.2026.201208}
}
Kostenlos starten →